{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:37:20Z","timestamp":1772570240285,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ajog.2025.03.030","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:34:01Z","timestamp":1743136441000},"page":"303.e1-303.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Presence of atypical extravillous trophoblast foci is an independent predictor of the risk of progression to postmolar neoplasia"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-9897","authenticated-orcid":false,"given":"Sophie","family":"Schoenen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katty","family":"Delbecque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Marbaix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Noel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Delvenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Van Rompuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Van Nieuwenhuysen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Kridelka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Adrien","family":"Bolze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.03.030_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2025.03.030_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2025.03.030_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","article-title":"Gestational trophoblastic neoplasia, FIGO 2000 staging and classification","volume":"83","author":"Ngan","year":"2003","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.03.030_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajog.2010.06.072","article-title":"Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia","volume":"204","author":"Lurain","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib5","first-page":"81","article-title":"Risk factors for persistent gestational trophoblastic neoplasia","volume":"9","author":"Kuyumcuoglu","year":"2011","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.ajog.2025.03.030_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0090-8258(88)90046-7","article-title":"The problem of identification of prognostic factors for persistent trophoblastic disease","volume":"30","author":"Parazzini","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.03.030_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00404-022-06785-w","article-title":"Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia","volume":"307","author":"Rakprasit","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2025.03.030_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1525-1438.2007.00993.x","article-title":"Early identification of persistent trophoblastic disease with serum hCG concentration ratios","volume":"18","author":"van Trommel","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.03.030_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2021.09.016","article-title":"Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement","volume":"163","author":"Hoeijmakers","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.03.030_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2011.10.003","article-title":"Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study","volume":"160","author":"Kim","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2025.03.030_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/IGC.0b013e31829703ea","article-title":"Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia","volume":"23","author":"Lybol","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.03.030_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12874-015-0106-y","article-title":"Early diagnosis of gestational trophoblastic neoplasia based on trajectory classification with compartment modeling","volume":"16","author":"Burny","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajog.2025.03.030_bib13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2011.10.035","article-title":"Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole","volume":"124","author":"Kang","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.03.030_bib14","first-page":"213","article-title":"Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease","volume":"59","author":"Petts","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ajog.2025.03.030_bib15","doi-asserted-by":"crossref","first-page":"372.e1","DOI":"10.1016\/j.ajog.2020.09.048","article-title":"Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression","volume":"224","author":"Lin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib16","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.2353\/ajpath.2010.091263","article-title":"p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease","volume":"176","author":"Siu","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2025.03.030_bib17","doi-asserted-by":"crossref","first-page":"336.e1","DOI":"10.1016\/j.ajog.2016.04.010","article-title":"Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia","volume":"215","author":"Braga","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/modpathol.2010.216","article-title":"Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome","volume":"24","author":"Mak","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajog.2025.03.030_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ygyno.2006.04.015","article-title":"Evaluation of deletions in 7q11.2 and 8p12-p21 as prognostic indicators of tumour development following molar pregnancy","volume":"103","author":"Burke","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.03.030_bib20","first-page":"1007","article-title":"Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value","volume":"9","author":"van de Kaa","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajog.2025.03.030_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5858\/arpa.2018-0234-RA","article-title":"Gestational trophoblastic tumors: a timely review of diagnostic pathology","volume":"143","author":"Hui","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2025.03.030_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13669-013-0075-2","article-title":"Classification and morphology of gestational trophoblastic disease","volume":"3","author":"Horn","year":"2014","journal-title":"Curr Obstet Gynecol Rep"},{"key":"10.1016\/j.ajog.2025.03.030_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ijgc-2021-003312","article-title":"Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry","volume":"32","author":"Schoenen","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.03.030_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-023-03658-8","article-title":"Practical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform moles","volume":"484","author":"Bartosch","year":"2024","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.ajog.2025.03.030_bib25","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1007\/s43032-021-00634-y","article-title":"Loss of selenoprotein iodothyronine deiodinase 3 expression correlates with progression of complete hydatidiform mole to gestational trophoblastic neoplasia","volume":"28","author":"St Laurent","year":"2021","journal-title":"Reprod Sci Thousand Oaks Calif"},{"key":"10.1016\/j.ajog.2025.03.030_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.21106\/ijma.108","article-title":"Diagnosis, treatment and outcome of gestational trophoblastic neoplasia in a low resource income country","volume":"5","author":"Gueye","year":"2016","journal-title":"Int J MCH AIDS"},{"key":"10.1016\/j.ajog.2025.03.030_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9378(47)90445-6","article-title":"Hydatidiform mole; a pathologico-clinical correlation of 200 cases","volume":"53","author":"Hertig","year":"1947","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib28","series-title":"Tumours of the female sex organs, Part I: hydatidiform mole and choriocarcinoma","author":"Hertig","year":"1956"},{"key":"10.1016\/j.ajog.2025.03.030_bib29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0002-9378(62)90065-0","article-title":"Malignant change in trophoblastic tumors","volume":"84","author":"Douglas","year":"1962","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0002-9378(54)90496-2","article-title":"Benign trophoblastic lesions in Mathieu Chorionepithelioma Registry (hydatidiform mole, syncytial endometritis)","volume":"68","author":"Novak","year":"1954","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1471-0528.1967.tb14878.x","article-title":"The value of histological grading in the prognostication of hydatidiform mole","volume":"74","author":"Tow","year":"1967","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2025.03.030_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1471-0528.1972.tb12907.x","article-title":"The value of histological grading in the management of hydatidiform mole","volume":"79","author":"Elston","year":"1972","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2025.03.030_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.AOG.0000174583.51617.25","article-title":"Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy","volume":"106","author":"Wolfberg","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ygyno.2006.10.012","article-title":"Assessment of Her-2\/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia","volume":"104","author":"Menczer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.03.030_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1471-0528.1979.tb10694.x","article-title":"An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy","volume":"86","author":"Stone","year":"1979","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/AOG.0b013e3181802186","article-title":"Maternal age-related rates of gestational trophoblastic disease","volume":"112","author":"Altman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.hoc.2024.07.003","article-title":"Epidemiology of gestational trophoblastic disease","volume":"38","author":"Joneborg","year":"2024","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ajog.2025.03.030_bib38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2005.03.012","article-title":"Second curettage in persistent trophoblastic disease (PTD): the need for univocal definition of PTD","volume":"99","author":"van Trommel","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.03.030_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejogrb.2020.12.001","article-title":"Curative effect of second curettage for treatment of gestational trophoblastic disease - results of the Belgian registry for gestational trophoblastic disease","volume":"257","author":"Vandewal","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2025.03.030_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AOG.0000000000001554","article-title":"Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia","volume":"128","author":"Osborne","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/plac.2002.0875","article-title":"How many paraffin blocks are necessary to detect villitis?","volume":"24","author":"Altemani","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2025.03.030_bib42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2025.03.030_bib43","first-page":"732","article-title":"Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation","volume":"101","author":"Feltmate","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.03.030_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0301-2115(03)00274-4","article-title":"How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data","volume":"112","author":"Batorfi","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2025.03.030_bib45","first-page":"CD007289","article-title":"Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia","volume":"2017","author":"Wang","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2025.03.030_bib46","first-page":"110","article-title":"Prophylactic actinomycin D for high-risk complete hydatidiform mole","volume":"46","author":"Limpongsanurak","year":"2001","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ajog.2025.03.030_bib47","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41419-021-04315-1","article-title":"miR-497-5p\/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation","volume":"12","author":"Peng","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajog.2025.03.030_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.humpath.2016.03.012","article-title":"SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor","volume":"54","author":"Stichelbout","year":"2016","journal-title":"Hum Pathol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825001760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:30:54Z","timestamp":1761431454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825001760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0002937825001760"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.03.030","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presence of atypical extravillous trophoblast foci is an independent predictor of the risk of progression to postmolar neoplasia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}